Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Digoxin | 2 | 2018 | 68 | 0.77 | Why? |
| Lung Diseases, Obstructive | 1 | 2018 | 46 | 0.72 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 0.59 | Why? |
| Elasticity Imaging Techniques | 1 | 2015 | 194 | 0.51 | Why? |
| Calcinosis | 1 | 2015 | 240 | 0.49 | Why? |
| National Health Programs | 1 | 2017 | 807 | 0.40 | Why? |
| Coronary Disease | 1 | 2015 | 645 | 0.39 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.37 | Why? |
| Databases, Factual | 4 | 2021 | 6248 | 0.33 | Why? |
| Atrial Fibrillation | 2 | 2018 | 2320 | 0.32 | Why? |
| Republic of Korea | 11 | 2021 | 5858 | 0.29 | Why? |
| Liver Cirrhosis | 1 | 2015 | 1810 | 0.26 | Why? |
| Insurance Carriers | 1 | 2021 | 41 | 0.21 | Why? |
| Coronary Artery Disease | 1 | 2015 | 2570 | 0.21 | Why? |
| Psychoses, Substance-Induced | 1 | 2021 | 91 | 0.21 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.18 | Why? |
| Gonadal Steroid Hormones | 1 | 2020 | 328 | 0.17 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.15 | Why? |
| Elasticity | 1 | 2015 | 70 | 0.15 | Why? |
| Propensity Score | 3 | 2021 | 2690 | 0.15 | Why? |
| Anti-Arrhythmia Agents | 1 | 2018 | 325 | 0.15 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.14 | Why? |
| Suicidal Ideation | 1 | 2021 | 1226 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2018 | 552 | 0.11 | Why? |
| Aortic Valve | 1 | 2018 | 664 | 0.11 | Why? |
| Cohort Studies | 9 | 2021 | 36005 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 1454 | 0.11 | Why? |
| Medical Informatics | 1 | 2017 | 648 | 0.10 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.09 | Why? |
| Antihypertensive Agents | 1 | 2021 | 1962 | 0.09 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Influenza, Human | 3 | 2021 | 10779 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| Internationality | 1 | 2021 | 3297 | 0.09 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.08 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 907 | 0.08 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.06 | Why? |
| Spain | 4 | 2021 | 15545 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.06 | Why? |
| Administrative Claims, Healthcare | 1 | 2021 | 124 | 0.06 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.06 | Why? |
| Liver | 1 | 2015 | 4007 | 0.05 | Why? |
| Male | 13 | 2021 | 367725 | 0.05 | Why? |
| Models, Theoretical | 1 | 2019 | 6659 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Aged | 10 | 2021 | 215776 | 0.05 | Why? |
| Fluoroquinolones | 1 | 2021 | 235 | 0.05 | Why? |
| United States | 6 | 2021 | 46150 | 0.05 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.05 | Why? |
| Acetaminophen | 1 | 2021 | 326 | 0.04 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.04 | Why? |
| Humans | 17 | 2021 | 930598 | 0.04 | Why? |
| American Heart Association | 1 | 2019 | 347 | 0.04 | Why? |
| Bundle-Branch Block | 1 | 2018 | 127 | 0.04 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Germany | 2 | 2021 | 9196 | 0.04 | Why? |
| Calcium Channel Blockers | 1 | 2017 | 367 | 0.03 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.03 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.03 | Why? |
| Bibliometrics | 1 | 2019 | 731 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Quality of Health Care | 1 | 2021 | 1948 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Cardiology | 1 | 2019 | 2873 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.02 | Why? |
| Europe | 1 | 2019 | 12702 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |